Skip to main content
OpenTrials
Completed

NCT Number: NCT06110351

Acute Clinical Outcomes of Hemorrhagic Myocardial Infarction

Acute clinical outcomes 1. Mortality 2. Arrhythmia 3. Readmission 4. CVA 5. ADHF

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

IU Methodist Hospital

Indianapolis, Indiana, 46202, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-85 years of age
  • Primary PCI
  • Post-PCI cardiac biomarker labs

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: 30-days and 6 months

    Prevalence of acute mortality

Secondary outcomes

  1. Acute heart failure

    Time frame: 30-days and 6 months

    Prevalence of acute heart failure

  2. Arrhythmia

    Time frame: 30-days and 6 months

    Prevalence of acute arrhythmia

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Acronym: MIRON-ACUTE

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 31, 2023
Registry last updated
Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.